PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Close Notification

Your cart does not contain any items

$425.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Academic Press Inc
12 December 2022
Anti-Aging Pharmacology provides an overview of current research aimed at the pharmacological modulation of aging including a discussion of the growing number of novel drug classes with promising anti-aging potential. The aging process is the main risk factor for all chronic diseases affecting the elderly. With lifespans extending across the globe, these chronic diseases are placing a larger burden on individuals and health care systems. Therefore, slowing down the aging rate could be more effective in delaying aging-associated chronic disorders than combating them one by one, which is the conventional approach in a current disease-based pharmacological paradigm. Different drug classes shown to have pro-longevity properties in experimental models are being increasingly developed and investigated in pre-clinical and clinical trials to determine whether they have anti-aging potential as well. This book contains work of the world's leading researchers in the field. It begins with the conceptual and methodological background of anti-aging pharmacology, explains the basic classes of anti-aging drugs, explores phytochemicals, and finally looks to outcomes of anti-aging developments and future directions. Anti-Aging Pharmacology will be of interest to a wide audience, ranging from pharmacologists, medicinal chemists, and academic researchers in gerontology, biomedical sciences, and those in medical practice.

Edited by:  
Imprint:   Academic Press Inc
Country of Publication:   United States
Dimensions:   Height: 235mm,  Width: 191mm, 
ISBN:   9780128236796
ISBN 10:   0128236795
Pages:   465
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active

Dr. Vaiserman is head of the Laboratory of Epigenetics at the Institute of Gerontology, where his research has focused on long-term health consequences of adverse conditions in early life, genetic and epigenetic mechanisms of age-associated diseases, telomere length in patients with age-related chronic diseases, and molecular mechanisms mediating lifespan in Drosophila. He earned his PhD from the Institute of Gerontology, Kiev, Ukraine in 2004. During the last 7 years, Dr. Vaiserman was Project Leader for several Ukrainian government sponsored research projects. Dr. Vaiserman is also a member of the editorial boards of the journals Biogerontology, Frontiers in Genetics of Aging, and Gerontology & Geriatric Research. To-date, he has published four book chapters, as well as 65 papers in peer reviewed journals.

See Also